BOCH
GPCR icon

Blue Owl Capital Holdings’s Structure Therapeutics GPCR Stock Holding History

Blue Owl Capital Holdings’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25K Buy
+100,000
New +$6.84M 0.01% 61

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Blue Owl Capital Holdings's GPCR Position: Q4 2024 in Review

Blue Owl Capital Holdings sold out of Structure Therapeutics (GPCR) in Q4 2024, closing a stake of 65,000 shares — an estimated $2.85M sold.

Blue Owl Capital Holdings first reported a position in GPCR in Q2 2024 and held it in 2 quarters. The position peaked at $2.85M in Q3 2024. 164 funds tracked by Wall St. Rank hold GPCR as of Q4 2024.

  • Blue Owl Capital Holdings reported no remaining Structure Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Blue Owl Capital Holdings sold 65,000 Structure Therapeutics shares in Q4 2024, an estimated $2.85M.
  • Blue Owl Capital Holdings first reported a position in Structure Therapeutics in Q2 2024 and held it in 2 quarters.
  • Blue Owl Capital Holdings's Structure Therapeutics position peaked at $2.85M in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2024.

Based on Blue Owl Capital Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.